ClinicalTrials.govpublic full text
CRISPR Delivered Anti-BCMA Car-T Therapy for Relapsed or Refractory Multiple Myeloma
multiple myeloma, recurrent multiple myeloma, refractory multiple myeloma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 463724
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.